We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. WASHINGTON — Patients with inflammatory arthritis who ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Among targeted therapies, patients with VEXAS syndrome ...
A first-in-human study of DYP688, an antibody drug conjugate delivering a direct Gq/11 inhibitor, in patients with metastatic uveal melanoma (MUM) and other GNAQ/11 mutant melanomas. This is an ASCO ...
Under normal conditions, cytokines aid in pathogen recognition and elimination while contributing to immune system ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback